Form 8-K CYTORI THERAPEUTICS, For: Mar 12
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Cytori Therapeutics (CYTX) Files $40M Common Shelf
March 16, 2015 5:04 PM EDTCytori Therapeutics (NASDAQ: CYTX) filed to sell up to $40 million worth of its Common Stock.
... MoreCytori Therapeutics (CYTX) Reports In-Line Q4 EPS
March 12, 2015 4:35 PM EDTCytori Therapeutics (NASDAQ: CYTX) reported Q4 EPS of ($0.08), in-line with the analyst estimate of ($0.08). Revenue for the quarter came in at $2.47 million versus the consensus estimate of $3.1 million.
For earnings history and earnings-related data on Cytori Therapeutics (CYTX) click here.
... MoreCytori Therapeutics (CYTX) Regains Nasdaq Listing Compliance
March 12, 2015 2:42 PM EDTOn March 12, 2015, Cytori Therapeutics (NASDAQ: CYTX) received written notification from The NASDAQ Stock Market LLC (NASDAQ) that it has regained compliance with the Nasdaq Stock Market Listing Rule 5450(a)(1) concerning the Companys closing bid price. The Company previously received written notification from NASDAQ indicating... More
